Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTIX | MRNA | BMY | AMGN | BNTX |
| Company | Protagenic Therapeutics Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Biontech Se ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.6000 | 111.05 | 49.00 | 270.63 | 88.59 |
| High | 1.7100 | 111.29 | 49.05 | 274.86 | 89.45 |
| Low | 1.3100 | 106.64 | 48.55 | 269.64 | 87.82 |
| Last | 1.6380 | 108.85 | 48.86 | 273.01 | 88.09 |
| Change | +0.0680 | +0.96 | -0.13 | -0.53 | -0.40 |
| % Change | +4.33% | +0.89% | -0.27% | -0.19% | -0.45% |
| Volume | 6,500 | 3,409,800 | 16,057,100 | 2,467,100 | 281,600 |
| 20-Day Average Volume | 11,090 | 3,227,090 | 11,258,950 | 2,172,705 | 578,505 |
| Previous Close | 1.5700 | 107.89 | 48.99 | 273.54 | 88.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5460 | 105.22 | 50.37 | 271.55 | 89.04 |
| 20-Day Raw Stochastic | 67.62% | 62.73% | 18.15% | 44.22% | 31.86% |
| 20-Day Relative Strength | 59.68% | 56.47% | 41.15% | 48.18% | 44.27% |
| Weighted Alpha | +11.16 | -8.40 | -26.02 | +11.15 | -23.84 |
| Today's Opinion | 64% Buy | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Previous Opinion | 56% Buy | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 40% Buy | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.33% since 04/17/24 | +5.23% since 04/17/24 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +1.96% since 04/17/24 |
| Low | 1.2499 on 04/19/24 | 99.30 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 85.61 on 04/18/24 |
| High | 1.8000 on 04/23/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 89.52 on 04/23/24 |
| 1-Month | |||||
| %Chg | +5.68% since 03/22/24 | +3.24% since 03/22/24 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | -4.07% since 03/22/24 |
| Low | 1.1535 on 04/17/24 | 97.00 on 04/03/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 85.40 on 04/17/24 |
| High | 1.8700 on 03/27/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 93.84 on 03/28/24 |
| 3-Month | |||||
| %Chg | +74.26% since 01/24/24 | +7.66% since 01/24/24 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | -10.93% since 01/24/24 |
| Low | 0.7600 on 01/29/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 85.21 on 03/20/24 |
| High | 1.8700 on 03/27/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 99.25 on 01/25/24 |
| 6-Month | |||||
| %Chg | +92.68% since 10/24/23 | +36.47% since 10/24/23 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | -8.05% since 10/24/23 |
| Low | 0.6797 on 12/04/23 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 85.21 on 03/20/24 |
| High | 1.8700 on 03/27/24 | 115.97 on 01/08/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 114.69 on 01/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,963 | 41,308,924 | 99,290,928 | 146,720,288 | 21,036,372 |
| Shares Outstanding, K | 4,435 | 382,880 | 2,026,759 | 536,376 | 237,726 |
| Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 4,133,300,000 |
| Annual Net Income | -5,000,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 1,006,860,000 |
| Last Quarter Sales | 0 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 1,605,270,000 |
| Last Quarter Net Income | -1,680,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 500,620,000 |
| 60-Month Beta | 0.36 | 1.62 | 0.39 | 0.58 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 04/01/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 2.05 on 03/20/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 04/25/24 | 05/02/24 | 05/06/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 3.084 on 06/02/22 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/02/22 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.55 | 14.58 | 21.36 |